Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2023-182812

Published: 2023

Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 4274.

https://doi.org/10.1182/blood-2023-182832

Published: 2023

Journal Articles

NPM1 Mutation Reprograms Leukemic Transcription Network Via Reshaping CTCF-Defined TAD Topology

Karina Hamamoto, Qian Lai, Huacheng Luo, Julia Lesperance, Zachary Zaroogian, Jie Zha, Yi Qiu, Olga A Guryanova, Bing Xu, Suming Huang

Blood (2022) 140 (Supplement 1): 722–723.

https://doi.org/10.1182/blood-2022-160367

Published: 2022

Journal Articles

Novel Therapeutic Combining CS055 with Chiglitazar Targets Leukemia Stem and Progenitor Cells in Acute Myeloid Leukemia

Hui Zhou, Dongmei Qin, Chendi Xie, Jie Zhou, Wenjuan Li, Mengya Zhong, Yuelong Jiang, Manman Deng, Haijun Zhao, Yong Zhou, Qian Lai, Zhihong Fang, Yiming Luo, Bing Xu, Jie Zha

Blood (2022) 140 (Supplement 1): 11731.

https://doi.org/10.1182/blood-2022-166807

Published: 2022

Journal Articles

Orelabrutinib and Venetoclax Show Synergistic Lethality in Double-Hit Lymphoma By Interfering with the Crosstalk between the PI3K/AKT and p38/MAPK Signaling

Mengya Zhong, Guangchao Pan, Jie Zha, Bing Xu

Blood (2022) 140 (Supplement 1): 11566–11567.

https://doi.org/10.1182/blood-2022-159944

Published: 2022

Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3292–3293.

https://doi.org/10.1182/blood-2022-165261

Published: 2022

Journal Articles

Clinical Characteristics and Outcomes of Follicular Lymphoma Patients with Extranodal Involvement: Analysis of a Series of 1090 Cases in China

Blood (2022) 140 (Supplement 1): 11979–11980.

https://doi.org/10.1182/blood-2022-162488

Published: 2022

Journal Articles

Preclinical Studies of Chiauranib Inhibit Follicular Lymphoma through VEGFR2/ERK/STAT3 Signaling Pathway

Yuanfang Tang, Mengya Zhong, Jie Zha, Bing Xu

Blood (2022) 140 (Supplement 1): 11578.

https://doi.org/10.1182/blood-2022-162456

Published: 2022

Journal Articles

Identification of Hub Genes and Pathways Associated with Follicular Lymphoma (FL) Via Bioinformatics Analysis

Yirong Jiang, Jingwei Yao, Mengya Zhong, Zhuoxin Yao, Zhangkun Li, Ziying Fan, Jie Zha, Bing Xu

Blood (2022) 140 (Supplement 1): 11959.

https://doi.org/10.1182/blood-2022-165258

Published: 2022

Journal Articles

Low-Dose Triptolide Promotes MDM2 Inhibitor Nutlin3a to Induce Acute Myeloid Leukemia Cell Death Via p53-Dependent and -Independent Mechanisms

Qinwei Chen, MD PhD, Suqi Deng, MS, Zhijuan Lin, MD PhD, Manman Deng, MD PhD, Lihong Ding, MS, Jie Zha, MD PhD, Yong Zhou, MS, Yuelong Jiang, MS, Bing Z Carter, PhD, Bing Xu, MD PhD

Blood (2020) 136 (Supplement 1): 24.

https://doi.org/10.1182/blood-2020-141315

Published: 2020

Journal Articles

Simultaneous Inhibition of Mcl-1 and Induction of DNA Damage Accumulation By Chidamide, a Novel Selective HDACi, Potentiates the Cytotoxicity of ABT-199 in Acute Myeloid Leukemia

Bing Xu, Kai Chen, Qianying Yang, Jie Zha, Haijun Zhao, Liying Feng, Xiaolei Chen, Guo Fu, Ken H. Young, MD PhD

Blood (2019) 134 (Supplement_1): 5767.

https://doi.org/10.1182/blood-2019-121721

Published: 2019

Journal Articles

Activation of Hottip lncrna Perturbs HSC Function Leading to AML like Disease in Mice

Huacheng Luo, Ganqian Zhu, PhD, Jie Zha, MD, Bowen Yan, Ph. D, Ying Guo, Jianfeng Xu, PhD, Qian Lai, Bing Xu, MD PhD, Feng-Chun Yang, MD PhD, Wei Li, Yi Qiu, Mingjiang Xu, MD PhD, Suming Huang

Blood (2018) 132 (Supplement 1): 3877.

https://doi.org/10.1182/blood-2018-99-110218

Published: 2018

Journal Articles

CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia

Huacheng Luo, Fei Wang, Jie Zha, Haoli Li, Bowen Yan, Qinghua Du, Fengchun Yang, Amin Sobh, Christopher Vulpe, Leylah Drusbosky, Christopher Cogle, Iouri Chepelev, Bing Xu, Stephen D. Nimer, Jonathan Licht, Yi Qiu, Baoan Chen, Mingjiang Xu, Suming Huang

Blood (2018) 132 (8): 837–848.

https://doi.org/10.1182/blood-2017-11-814319

Published: 2018

Includes: Supplemental data

Journal Articles

Disregulation of CTCF Boundary at the HOX Locus Enhances Sensitity to Multiple Drug Treatment in Myeloid Malignancies

Jie Zha, MD, Huacheng Luo, PhD, Yi Qiu, PhD, Suming Huang, PhD

Blood (2017) 130 (Supplement 1): 3816.

https://doi.org/10.1182/blood.V130.Suppl_1.3816.3816

Published: 2017

Journal Articles

Apatinib Inhibits Proliferation and Induces Apoptosis of Acute Myeloid Leukemia Stem/Progenitor like Cell Line(kg1α cells) By Inhibition PI3K/AKT Signal Pathway

Bing Xu, PhD, Zhi-feng Li, Man-man Deng, Jie Zha, Yong Zhou, Zhi-hong Fang, PhD

Blood (2016) 128 (22): 5134.

https://doi.org/10.1182/blood.V128.22.5134.5134

Published: 2016

Journal Articles

Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2

Bing Xu, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Rongwei Li, MD, Huijuan Dong, MD, Jie Zha, M.D.

Blood (2013) 122 (21): 4928.

https://doi.org/10.1182/blood.V122.21.4928.4928

Published: 2013

Journal Articles

Activation of Oxidative Stress and Down-Regulation of Nuclear Factor Erythroid 2-Related Factor May Be Responsible for Disulfiram/Copper Complex Induced Apoptosis in Lymphoid Malignancy Cell Lines

Feili Chen, M.D., Jie Zha, M.D., Yanyan Zhang, M.D., Pengcheng Shi, M.D., Xutao Guo, M.D., Shiyun Wang, M.D., Weiguang Wang, M.D. PhD, Bing Xu, M.D. PhD

Blood (2012) 120 (21): 4869.

https://doi.org/10.1182/blood.V120.21.4869.4869

Published: 2012

Journal Articles

Low MDR1 and BAALC expression Identifies a New Subgroup of Adult Cytogenetically Normal Acute Myeloid Leukemia with a Favorable Outcome

Xutao Guo, M.D., Feili Chen, M.D., Pengcheng Shi, M.D., Jie Zha, M.D., Bingshan Liu, M.D., Haiqing Zheng, Bing Xu, M.D. PhD

Blood (2012) 120 (21): 4312.

https://doi.org/10.1182/blood.V120.21.4312.4312

Published: 2012

Journal Articles

Comparative Efficacy of Homoharringtonine Plus Cytarabine and Decitabine in Patients with MDS/AML

Yuejian Liu, M.D., Feili Chen, M.D., Xutao Guo, M.D., Pengcheng Shi, M.D., Jie Zha, M.D., Zhiping Fan, Fen Huang, M.D., Bing Xu, M.D. PhD

Blood (2012) 120 (21): 4340.

https://doi.org/10.1182/blood.V120.21.4340.4340

Published: 2012

Journal Articles

Disulfiram, an Clinically Used Anti-Alcoholism Drug Has the Potential to Target Leukemia Stem and Progenitor Cells in a Copper-Dependent Manner

Bing Xu, M.D. PhD, Shiyun Wang, M.D., Feili Chen, M.D., Pengcheng Shi, M.D., Jie Zha, M.D., Yanyan Zhang, M.D., Xutao Guo, M.D., Weiguang Wang, M.D. PhD

Blood (2012) 120 (21): 4088.

https://doi.org/10.1182/blood.V120.21.4088.4088

Published: 2012

NARROW

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

NPM1 Mutation Reprograms Leukemic Transcription Network Via Reshaping CTCF-Defined TAD Topology

Novel Therapeutic Combining CS055 with Chiglitazar Targets Leukemia Stem and Progenitor Cells in Acute Myeloid Leukemia

Orelabrutinib and Venetoclax Show Synergistic Lethality in Double-Hit Lymphoma By Interfering with the Crosstalk between the PI3K/AKT and p38/MAPK Signaling

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Clinical Characteristics and Outcomes of Follicular Lymphoma Patients with Extranodal Involvement: Analysis of a Series of 1090 Cases in China

Preclinical Studies of Chiauranib Inhibit Follicular Lymphoma through VEGFR2/ERK/STAT3 Signaling Pathway

Identification of Hub Genes and Pathways Associated with Follicular Lymphoma (FL) Via Bioinformatics Analysis

Low-Dose Triptolide Promotes MDM2 Inhibitor Nutlin3a to Induce Acute Myeloid Leukemia Cell Death Via p53-Dependent and -Independent Mechanisms

Simultaneous Inhibition of Mcl-1 and Induction of DNA Damage Accumulation By Chidamide, a Novel Selective HDACi, Potentiates the Cytotoxicity of ABT-199 in Acute Myeloid Leukemia

Activation of Hottip lncrna Perturbs HSC Function Leading to AML like Disease in Mice

CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia

Disregulation of CTCF Boundary at the HOX Locus Enhances Sensitity to Multiple Drug Treatment in Myeloid Malignancies

Apatinib Inhibits Proliferation and Induces Apoptosis of Acute Myeloid Leukemia Stem/Progenitor like Cell Line(kg1α cells) By Inhibition PI3K/AKT Signal Pathway

Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2

Activation of Oxidative Stress and Down-Regulation of Nuclear Factor Erythroid 2-Related Factor May Be Responsible for Disulfiram/Copper Complex Induced Apoptosis in Lymphoid Malignancy Cell Lines

Low MDR1 and BAALC expression Identifies a New Subgroup of Adult Cytogenetically Normal Acute Myeloid Leukemia with a Favorable Outcome

Comparative Efficacy of Homoharringtonine Plus Cytarabine and Decitabine in Patients with MDS/AML

Disulfiram, an Clinically Used Anti-Alcoholism Drug Has the Potential to Target Leukemia Stem and Progenitor Cells in a Copper-Dependent Manner

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only